Conversation with The Cancer Letter Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health April 25, 2025Vol.51 No.16By Paul Goldberg
Regulatory News Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas April 25, 2025Vol.51 No.16By Claire Marie Porter
PodcastThe Directors The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty“We are resolute. We are committed to continuing to move the work forward.” April 18, 2025Vol.51 No.15By Paul Goldberg
Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eightNCI to remain intact, but its finances are uncertain; FDA is spared big cuts April 18, 2025Vol.51 No.15By Paul Goldberg
Clinical Roundup Inherited cancer mutations may drive tumor growth, study shows April 18, 2025Vol.51 No.15
Podcast In The Headlines: Private funding can’t replace federal funding—but it can help April 09, 2025Vol.51 No.13
Guest Editorial Rathmell: We must put the individual at the center of our approach to ending cancer April 04, 2025Vol.51 No.13By W. Kimryn Rathmell
FreeIn the Archives In an oral history now taken down by FDA, Andrew von Eschenbach recounts his stint as the head of both FDA and NCI—simultaneously April 04, 2025Vol.51 No.13By Jacquelyn Cobb
